Granulomatous adenohypophysitis after interferon and ribavirin therapy

Endocrine Practice

Volumn 13, Issue 2, 2007, Pages 169-175

  Tebben, Peter J ^a   Atkinson, John L D ^a   Scheithauer, Bernd W ^a   Erickson, Dana ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; GRANULOMA; HEPATITIS C; HUMAN; HYPOPHYSIS DISEASE; HYPOPITUITARISM; PATHOLOGY; THYROIDITIS; THYROTOXICOSIS;

ADULT; ANTIVIRAL AGENTS; FEMALE; GRANULOMA; HEPATITIS C; HUMANS; HYPOPITUITARISM; INTERFERON ALFA-2B; PITUITARY DISEASES; RIBAVIRIN; THYROIDITIS; THYROTOXICOSIS;

EID: 34447338624     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.13.2.169     Document Type: Article

References (48)

1. McHutchison JG, Gordon SC, Schiff ER, et al (Hepatitis Interventional Therapy Group). Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med. 1998;339:1485-1492.
2. Kjaergard LL, Krogsgaard K, Gluud C. Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials. BMJ. 2001;323:1151-1155.
3. Zeuzem S, Feinman SV, Rasenack J, et al. Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med. 2000;343:1666-1672.
4. Carella C, Mazziotti G, Morisco F, et al. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J Clin Endocrinol Metab. 2001;86:1925-1929.
5. Carella C, Mazziotti G, Morisco F, et al. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. Eur J Endocrinol. 2002;146:743-749.
6. Wong V, Fu AX, George J, Cheung NW. Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis. Clin Endocrinol (Oxf). 2002;56:793-798.
7. Bini EJ, Mehandru S. Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study. Arch Intern Med. 2004;164:2371-2376.
8. Doi F, Kakizaki S, Takagi H, et al. Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C. Liver Int. 2005;25:242-246.
9. Lin YQ, Wang X, Murthy MS, Agarwala S. Life-threatening thyrotoxicosis induced by combination therapy with PEG-interferon and ribavirin in chronic hepatitis C. Endocr Pract. 2005;11:135-139.
10. Parana R, Cruz M, Lyra L, Cruz T. Subacute thyroiditis during treatment with combination therapy (interferon plus ribavirin) for hepatitis C virus. J Viral Hepat. 2000;7:393-395.
11. Nakajima M, Kubota Y, Miyashita N, Niki Y, Matsushima T, Manabe T. Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C. Intern Med. 1996;35:376-379.
12. Hurst EA, Mauro T. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Arch Dermatol. 2005;141:865-868.
13. Nawras A, Alsolaiman MM, Mehboob S, Bartholomew C, Maliakkal B. Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature. Dig Dis Sci. 2002;47:1627-1631.
14. Wendling J, Descamps V, Grossin M, et al. Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C. Arch Dermatol. 2002;138:546-547.
15. Rubinowitz AN, Naidich DP, Alinsonorin C. Interferon-induced sarcoidosis. J Comput Assist Tomogr. 2003;27:279-283.
16. Pietropaoli A, Modrak J, Utell M. Interferon-alpha therapy associated with the development of sarcoidosis. Chest. 1999;116:569-572.
17. Teragawa H, Hondo T, Takahashi K, et al. Sarcoidosis after interferon therapy for chronic active hepatitis C. Intern Med. 1996;35:19-23.
18. Gitlin N. Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases. Eur J Gastroenterol Hepatol. 2002;14:883-885.
19. Tsiodras S, Drimala P, Stavreas N, Dachlythras M, Alamani AM, Naoum G. Uterine sarcoidosis potentially associated with interferon-alpha use for chronic hepatitis C infection. Obstet Gynecol. 2005;105(5 Pt 2):1198-1201.
20. Butnor KJ. Pulmonary sarcoidosis induced by interferonalpha therapy. Am J Surg Pathol. 2005;29:976-979.
21. Papaioannides D, Fotinou M, Korantzopoulos P, et al. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. Med Sci Monit. 2004;10:CS5-CS7.
22. Luchi S, Scasso A. Sarcoidosis, chronic hepatitis C and interferon-alpha: two cases [letter]. Scand J Infect Dis. 2003;35:775-776.
23. Miwa H, Furuya T, Tanaka S, Mizuno Y. Neurosarcoidosis associated with interferon therapy. Eur Neurol. 2001;45:288-289.
24. Sakane N, Yoshida T, Yoshioka K, Umekawa T, Kondo M, Shimatsu A. Reversible hypopituitarism after interferonalfa therapy [letter]. Lancet. 1995;345:1305.
25. Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ. Pituitary involvement by Wegener's granulomatosis: a report of two cases. AJNR Am J Neuroradiol. 1999;20:519-523.
26. Roberts GA, Eren E, Sinclair H, et al. Two cases of Wegener's granulomatosis involving the pituitary. Clin Endocrinol (Oxf). 1995;42:323-328.
27. Goyal M, Kucharczyk W, Keystone E. Granulomatous hypophysitis due to Wegener's granulomatosis. AJNR Am J Neuroradiol. 2000;21:1466-1469.
28. Woywodt A, Knoblauch H, Kettritz R, Schneider W, Gobel U. Sudden death and Wegener's granulomatosis of the pituitary. Scand J Rheumatol. 2000;29:264-266.
29. Guoth MS, Kim J, de Lotbiniere AC, Brines ML. Neurosarcoidosis presenting as hypopituitarism and a cystic pituitary mass. Am J Med Sci. 1998;315:220-224.
30. Bakshi R, Fenstermaker RA, Bates VE, Ravichandran TP, Goodloe S Jr, Kinkel WR. Neurosarcoidosis presenting as a large suprasellar mass: magnetic resonance imaging findings. Clin Imaging. 1998;22:323-326.
31. Flanagan DE, Ibrahim AE, Ellison DW, Armitage M, Gawne-Cain M, Lees PD. Inflammatory hypophysitis-the spectrum of disease. Acta Neurochir (Wien). 2002;144:47-56.
32. Roncaroli F, Bacci A, Frank G, Calbucci F. Granulomatous hypophysitis caused by a ruptured intrasellar Rathke's cleft cyst: report of a case and review of the literature. Neurosurgery. 1998;43:146-149.
33. Toth M, Szabo P, Racz K, et al. Granulomatous hypophysitis associated with Takayasu's disease. Clin Endocrinol (Oxf). 1996;45:499-503.
34. de Bruin WI, van't Verlaat JW, Graamans K, de Bruin TW. Sellar granulomatous mass in a pregnant woman with active Crohn's disease. Neth J Med. 1991;39:136-141.
35. Manghani DK, Gaitonde PS, Dastur DK. Pituitary tuberculoma - a case report. Neurol India. 2001;49:299-301.
36. Sharma MC, Arora R, Mahapatra AK, Sarat-Chandra P, Gaikwad SB, Sarkar C. Intrasellar tuberculoma - an enigmatic pituitary infection: a series of 18 cases. Clin Neurol Neurosurg. 2000;102:72-77.
37. Nadkarni TD, Menon RK, Desai KL, Goel A. A solitary cryptococcal granuloma in an immunocompetent host [letter]. Neurol India. 2005;53:365-367.
38. Pennetti G. Sindromi ipofisarie Malattia del Simmond e coma pituitario del Miermet. La Riforma Medica. 1928;44:9-13.
39. Isoo A, Ueki K, Ishida T, et al. Langerhans cell histiocytosis limited to the pituitary-hypothalamic axis - two case reports. Neurol Med-Chir (Tokyo). 2000;40:532-535.
40. Scholz M, Firsching R, Feiden W, Breining H, Brechtelsbauer D, Harders A. Gagel's granuloma (localized Langerhans cell histiocytosis) in the pituitary stalk. Clin Neurol Neurosurg. 1995;97:164-166.
41. Cheung CC, Ezzat S, Smyth HS, Asa SL. The spectrum and significance of primary hypophysitis. J Clin Endocrinol Metab. 2001;86:1048-1053.
42. Honegger J, Fahlbusch R, Bornemann A, et al. Lymphocytic and granulomatous hypophysitis: experience with nine cases [with discussion]. Neurosurgery. 1997;40:713-723.
43. Mueller B, Burgi U, Seiler R. Lymphocytic and granulomatous hypophysitis: experience with nine cases [letter]. Neurosurgery. 1999;44:426-427.
44. Gazioglu N. Lymphocytic and granulomatous hypophysitis: experience with nine cases [letter]. Neurosurgery. 2000;46:1268.
45. Gazioglu N, Tuzgen S, Oz B, et al. Idiopathic granulomatous hypophysitis: are there reliable, constant radiological and clinical diagnostic criteria? Neuroradiology. 2000;42:890-894.
46. Leung GK, Lopes MB, Thorner MO, Vance ML, Laws ER Jr. Primary hypophysitis: a single-center experience in 16 cases. J Neurosurg. 2004;101:262-271.
47. Deodhare SS, Bilbao JM, Kovacs K, et al. Xanthomatous hypophysitis: a novel entity of obscure etiology. Endocr Pathol. 1999;10:237-241.
48. Inoue T, Kaneko Y, Mannoji H, Fukui M. Giant cell granulomatous hypophysitis manifesting as an intrasellar mass with unilateral ophthalmoplegia - case report. Neurol Med-Chir (Tokyo). 1997;37:766-770.